...
首页> 外文期刊>International immunology. >Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.
【24h】

Differential contribution of the immunoreceptor tyrosine-based inhibitory motifs of human leukocyte-associated Ig-like receptor-1 to inhibitory function and phosphatase recruitment.

机译:人类白细胞相关的Ig样受体1的基于免疫受体酪氨酸的抑制基序对抑制功能和磷酸酶募集的不同贡献。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Leukocyte-associated Ig-like receptor (LAIR)-1 is an inhibitory receptor expressed on most human leukocytes. It contains two immunoreceptor tyrosine-based inhibitory motifs (ITIM) in its cytoplasmic tail and recruits phosphatases upon phosphorylation. Here we show that both ITIM are required for full inhibition of cellular responses and optimal phosphatase recruitment. Mutation of the C-terminal ITIM still allows partial inhibition of the cytotoxic activity of the NK-like YT.2C2 cells, while mutation of the N-terminal ITIM completely abolishes this inhibitory activity. In contrast, in rat basophilic leukemia (RBL) cells, both mutants of LAIR-1 are partially effective. This is reflected in phosphorylation of these mutants in the different cell types upon pervanadate treatment. However, in both YT.2C2 cells and RBL cells, only the mutant containing the N-terminal ITIM recruits Src homology 2 domain-containing tyrosine phosphatase-2 (SHP-2), while the mutant containing the C-terminal ITIM does not. In RBLcells the mutant containing only the N-terminal ITIM also binds SHP-1, although to a lesser extent than wild-type LAIR-1. We find that in Jurkat T cells Lck is required for the association of SHP-1 with LAIR-1. Co-expression with Lck in 293T cells leads to phosphorylation of both wild-type LAIR-1 and the mutant containing only the N-terminal ITIM, while the mutant lacking this ITIM is not phosphorylated. These results indicate that Lck, or another Src family kinase, is essential for the consecutive phosphorylation of the N- and C-terminal ITIM. Our data imply that the N-terminal ITIM is dominant in LAIR-1 signaling, but that both ITIM contribute to an optimal inhibitory function.
机译:白细胞相关的Ig样受体(LAIR)-1是在大多数人类白细胞上表达的抑制性受体。它的胞质尾部包含两个基于酪氨酸的免疫受体抑制基序(ITIM),并在磷酸化后募集磷酸酶。在这里,我们显示了两个ITIM都是完全抑制细胞反应和最佳磷酸酶募集所必需的。 C末端ITIM的突变仍然可以部分抑制NK样YT.2C2细胞的细胞毒活性,而N末端ITIM的突变则完全消除了这种抑制活性。相反,在大鼠嗜碱性粒细胞白血病(RBL)细胞中,LAIR-1的两个突变体均部分有效。这在过氧钒酸盐处理后在不同细胞类型中这些突变体的磷酸化中得到反映。但是,在YT.2C2细胞和RBL细胞中,仅包含N末端ITIM的突变体募集含有Src同源2域的酪氨酸磷酸酶2(SHP-2),而包含C末端ITIM的突变体则不募集。在RBL细胞中,仅包含N末端ITIM的突变体也结合SHP-1,尽管程度低于野生型LAIR-1。我们发现在Jurkat T细胞中,LHP是SHP-1与LAIR-1结合所必需的。在293T细胞中与Lck共表达会导致野生型LAIR-1和仅包含N末端ITIM的突变体的磷酸化,而缺少该ITIM的突变体不会被磷酸化。这些结果表明,Lck或另一种Src家族激酶对于N和C末端ITIM的连续磷酸化至关重要。我们的数据暗示N末端ITIM在LAIR-1信号传导中占主导地位,但是这两个ITIM均有助于最佳抑制功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号